Mallinger to discuss treatment resistant mood disorders
Dr. Alan G. Mallinger, M.D. will be speaking this Thursday -- July 19 -- at the Auditorium at George Washington University Hospital at 900 Twenty-Third St, Washington, DC. at 7:30 p.m. Dr. Mallinger will be speaking about Pathophysiology of Affective Disorders and Potential New Treatments for Treatment Resistant Mood Disorders. The event is sponsored by DBSA-National Capital Area.
Dr. Mallinger is the unit chief of the Adult Outpatient Clinic's Mood and Anxiety Disorders Program at the National Institute of Mental Health. He was a professor of psychiatry and pharmacology at the University of Pittsburgh School of Medicine and the director of the Psychopharmacology of Mania and Depression Program at the Western Psychiatric Institute and Clinic in Pittsburgh, Pennsylvania.
During his career, Dr. Mallinger has pursued parallel interests in clinical psychiatry and basic psychopharmacology research related to mood disorders. His areas of basic research interest include laboratory studies on cell membrane phenomena and intracellular signal transduction processes, specifically, as these relate to the biological aspects of bipolar disorder and to the therapeutic mechanisms of mood stabilizing drugs.
His clinical research interests include therapeutic options for treatment-resistant mania, mood stabilizer treatment during pregnancy, and pharmacokinetic studies of MAO inhibitors. He has been involved in various clinical trials on antidepressants, mood stabilizers, and psychotherapy. Dr. Mallinger has authored or co-authored 56 scientific articles and book chapters. He is currently Director of the Psychopharmacology of Mania and Depression basic research program at WPIC, as well as medical director of the Maintenance Therapies in Bipolar Disorder study, and the Stanley Center for the Innovative Treatment of Bipolar Disorder. He also served as chairperson of the Merit Review Committee for Mental Health and Behavioral Sciences for the Department of Veterans Affairs, Washington, D.C..
He is course director of the Pharmacotherapy Training in Mood Disorders Clinic and the Mood Disorders Seminar for psychiatry residents at the University of Pittsburgh.
Dr. Mallinger is the unit chief of the Adult Outpatient Clinic's Mood and Anxiety Disorders Program at the National Institute of Mental Health. He was a professor of psychiatry and pharmacology at the University of Pittsburgh School of Medicine and the director of the Psychopharmacology of Mania and Depression Program at the Western Psychiatric Institute and Clinic in Pittsburgh, Pennsylvania.
During his career, Dr. Mallinger has pursued parallel interests in clinical psychiatry and basic psychopharmacology research related to mood disorders. His areas of basic research interest include laboratory studies on cell membrane phenomena and intracellular signal transduction processes, specifically, as these relate to the biological aspects of bipolar disorder and to the therapeutic mechanisms of mood stabilizing drugs.
His clinical research interests include therapeutic options for treatment-resistant mania, mood stabilizer treatment during pregnancy, and pharmacokinetic studies of MAO inhibitors. He has been involved in various clinical trials on antidepressants, mood stabilizers, and psychotherapy. Dr. Mallinger has authored or co-authored 56 scientific articles and book chapters. He is currently Director of the Psychopharmacology of Mania and Depression basic research program at WPIC, as well as medical director of the Maintenance Therapies in Bipolar Disorder study, and the Stanley Center for the Innovative Treatment of Bipolar Disorder. He also served as chairperson of the Merit Review Committee for Mental Health and Behavioral Sciences for the Department of Veterans Affairs, Washington, D.C..
He is course director of the Pharmacotherapy Training in Mood Disorders Clinic and the Mood Disorders Seminar for psychiatry residents at the University of Pittsburgh.
posted by jayson blair at 5:40 AM
0 Comments:
Post a Comment
<< Home